Skip Navigation


NDT Advance Access originally published online on December 2, 2008
Nephrology Dialysis Transplantation 2009 24(2):689-690; doi:10.1093/ndt/gfn665
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/2/689    most recent
gfn665v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Renke, M.
Right arrow Articles by Rutkowski, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renke, M.
Right arrow Articles by Rutkowski, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease

E-mail: mrenke@amg.gda.pl

The first 10% of the full text of this article appears below.

Sir,

A pharmacological blockade of the renin–angiotensin–aldosterone system (RAAS) constitutes a cornerstone strategy for inhibiting progression of chronic nephropathies. In a recent NDT issue, Tomas Berl [1] discussed the improvements in renal outcome associated with maximal RAAS inhibition achieved . . . [Full Text of this Article]

Marcin Renke1, Leszek Tylicki1, Narcyz Knap2, Przemyslaw Rutkowski1, Alexander Neuwelt3, Andriy Petranyuk2, Wojciech Larczynski1, Michal Wozniak2 and Boleslaw Rutkowski1

1 Department of Nephrology Transplantology & Internal Medicine 2 Department of Medical Chemistry Medical University of Gdansk 7 Debinki St. 80-211 Gdansk Poland 3 Blood Brain Barrier and Neuro-Oncology Program Oregon Health & Science University, 3181 SW San Jackson Park Rd, Portland, OR 97239, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?